According to Rappoport: “In Sierra Leone, the Tulane group has been researching new diagnostic tests for haemorrhagic fevers. [Note: Lassa Fever, Ebola, and other labels are applied to a spectrum of illness that result in haemorrhaging].
“The Tulane researchers have also been investigating the use of monoclonal antibodies as a treatment for these fevers – but not on-site in Africa, according to Tulane press releases.
“Here are excerpts from supporting documents. Tulane University, Oct. 12, 2012, ‘Dean’s Update on Lassa Fever Research’:
“In 2009, researchers received a five-year $7, 073,538 grant from the National Institute of Health to fund the continued development of detection kits for Lassa viral haemorrhagic fever.
“…Since that time, much has been done to study the disease. Dr. Robert Garry, Professor of Microbiology and Immunology, and Dr. James Robinson, Professor of Pediatrics, have been involved in the research of Lassa fever.
“Together, the two have recently been able to create what are called human monoclonal antibodies … These antibodies have been tested on guinea pigs at The University of Texas Medical Branch in Galveston and shown to help prevent them from dying of Lassa fever…
“Most recently, a new Lassa fever ward is being constructed in Sierra Leone, at the Kenema Government Hospital [one of the centres of the Ebola outbreak]. When finished, it will be better equipped to assist patients affected by the disease and will hopefully help to end the spread of it.”
Rappoport continued: “Here is another release from the Tulane University, this one dated Oct. 18, 2007: ‘New Test Moves Forward to Detect Bio-terrorism Threats’.
“The initial round of clinical testing has been completed for the first diagnostic test kits that will aid in bio-terrorism defence against a deadly viral disease. Tulane University researchers are collaborating in the project.
“Robert Garry, professor of Microbiology and Immunology at Tulane University, is [the] principal investigator in a federally-funded study to develop new tests for viral haemorrhagic fevers. Corgenix Medical Corp., a worldwide developer and marketer of diagnostic test kits, announced that the first test kits for detection of haemorrhagic fever have competed initial clinical testing in West Africa.
“The kits, developed under a $3.8 million grant awarded by the National Institutes of Health, involve work by Corgenix in collaboration with Tulane University, the US Army Medical Research Institute of Infectious Diseases, BioFactura Inc, and Autoimmune Technologies.
“Clinical reports from the studies in Sierra Leone continue to show amazing results,” says Robert Garry, professor of Microbiology and Immunology at the Tulane University School of Medicine…
“We believe this remarkable collaboration will result in detection products that will truly have a meaningful impact on the healthcare in West Africa, but will also fill a badly needed gap in the bio-terrorism defence … The clinical studies are being conducted at the Mano River Union Lassa Fever Network in Sierra Leone.
“Tulane, under contract with the World Health Organisation, implements the program in the Mano River Union countries (Sierra Leone, Liberia and Guinea) to develop national and regional prevention and control strategies for Lassa fever and other important regional diseases …
“Clinical testing on the new recombinant technology demonstrates that our collaboration is working,” says Douglass Simpson, president of Corgenix.
“We have combined the skills of different parties, resulting in development of some remarkable test kits in a surprisingly short period of time. As a group, we intend to expand this program to address other important infectious agents with both clinical health issues and threat of bio-terrorism such as Ebola.”
According to Rappoport: “The third document is found on the Sierra Leone Ministry of Health and Sanitation Facebook page, dated July 23, 2014 at 1:35pm. It lays out emergency measures to be taken.
“We find this curious statement: ‘Tulane University to stop Ebola testing during the current Ebola outbreak.’ Why? Are the tests issuing false results? Are they frightening the population? Have Tulane researchers done something to endanger public health?
“In addition to an investigation of these matters, another probe needs to be launched into all vaccine campaigns in the Ebola Zone. For example, HPV vaccine programmes have been ongoing. Vials of vaccine must be tested to discover all ingredients. Additionally, it is well known that giving vaccines to people whose immune systems are already severely compromised is dangerous and deadly.”
A Concerned Ghanaian
As the concerned Ghanaian journalist, the veteran Cameron Duodu, put it: “There are enough questions in Jon Rappoport’s article for the US health authorities to issue an immediate and truthful statement on what the Tulane University and its associates have been doing in the very region from which Ebola has broken out and is in danger of affecting many other countries.
“In the age of the Wikileaks and the Snowden leaks, it was remiss of the US government not to anticipate that the research being done in Guinea, Sierra Leone and Liberia would be linked to the current Ebola outbreak, and issue a statement to avoid panicking the populations of those countries and their neighbours.
“The WHO must also tell the world what it knows about these tests in Sierra Leone, Guinea and Liberia and explain why it has not made the world aware of them up till now! Is the WHO totally convinced that full ethical standards have been met by the Tulane scientists during this outbreak which the WHO has classified as an ‘emergency’?
Duodu went on: “After all, there is a wealth of evidence to demonstrate that it is not altogether fanciful to suggest HIV-Aids, for instance, was probably spread initially by infected homosexuals in the US, and was brought to Africa by scientists who wished to find a cure for it. The WHO’s role in HIV-Aids research has not been fully explained. We need answers from the US government and the WHO. Now!”
I, Baffour Ankomah, rest my case. We shall see if the Americans will open their mouths about what they know, and did, in Sierra Leone, Guinea and Liberia before the current outbreak of Ebola.
By: Baffour Ankomah